BioSpace News Archive

Hugel America, Inc., a growth focused joint venture between aesthetic market-leading partners Hugel Inc., and Croma-Pharma GmbH, today announced that the Biologics License Application (BLA) for LetibotulinumtoxinA for Injection, to treat moderate to severe glabellar (frown) lines in adult patients has been accepted for review by the U.S. Food and Drug Administration (FDA).

Predictive Health Diagnostics Company, Inc. announced expansion of its sales representatives to meet the increasing physician demand of its specialty diagnostic tests throughout North America.

This update will include progress towards the initiation of the first clinical trial with PCLX-001 in the next month.

SGD Pharma announces that its 20ml EasyLyo molded glass Type I vials are now available Ready-to-Use (RTU) in SG EZ-fill® Nest & Tub – an industry-recognized state-of-the-art secondary packaging format.

Eton today announced that it has acquired U.S. and Canadian rights to Crossject’s ZENEO® hydrocortisone needleless autoinjector, which is under development as a rescue treatment for adrenal crisis.

Senti Biosciences, Inc., a leading gene circuit company, today announced that it has signed a lease agreement for a property in Alameda, California for the build-out of its wholly-owned cell therapy manufacturing facility.

Spero Therapeutics, Inc. today announced the initiation of two Phase 1 trials of SPR206, an intravenously (IV)-administered next-generation polymyxin product candidate.

Amphastar Pharmaceuticals, Inc. announced today that Bill Peters, Executive V.P. and CFO, Dan Dischner, V.P of Corporate Communications, Tony Marrs, Sr. V.P Regulatory Affairs and Clinical Operations, and Jacob Liawatidewi, Executive V.P. Corporate Administration Center and Sales & Marketing, will be presenting at the Human Health Innovation Conference on Tuesday, June 22, 2021, at 2:00 pm Eastern time.

Medexus Pharmaceuticals Inc. announced that it has received final approval for listing of the Company’s common shares on the Toronto Stock Exchange.

ANI Pharmaceuticals, Inc. will present at the Raymond James Human Health Innovation Conference 2021.